Last reviewed · How we verify
Treatment and/or Prevention of Urinary Tract Infections (UTI)
The purpose of the study is to determine the effect of an investigational oral rinse in reducing uropathogens and treating uncomplicated urinary tract infections.
Details
| Lead sponsor | Biomedical Development Corporation |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 3 |
| Start date | 2008-12 |
| Completion | 2009-06 |
Conditions
- Cystitis
- Urinary Tract Infections
Interventions
- Frio Mouth Rinse
Primary outcomes
- The primary efficacy endpoint is the reduction of the baseline pathogen at the Days 7 to 10 "Test of Cure" visit. — 7 to 10 Days
Countries
United States